Views & Analysis The NHS, new models of care and STPs: what role for pharma? These are challenging times in the NHS, with reforms and budget restrictions putting the health service under huge strain.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face